Depression and Impulsivity Self-Assessment Tools to Identify Dopamine Agonist Side Effects in Patients With Pituitary Adenomas.

Frontiers in Endocrinology
José Miguel Hinojosa-AmayaMaria Fleseriu

Abstract

Background: Dopamine agonists (DA) are the first line therapy for prolactinoma and symptomatic hyperprolactinemia; use as an adjuvant treatment for acromegaly and Cushing's disease is rare. Some patients develop de novo psychiatric symptoms or have exacerbation of pre-existing conditions during DA therapy. A practical, clinically sensitive depression and impulse control disorders (ICD; particularly hypersexuality and gambling disorders) detection tool is important for identifying at risk patients. The Barratt Impulsivity Scale (BIS-11) and the 9-item Patient Health Questionnaire (PHQ-9) are sensitive in identifying impulsivity and depression. Objective: Detail use of the BIS-11 and PHQ-9 as screening tools for depression and ICD in patients with pituitary disease at a high-volume academic pituitary center. Methods: DA-treated and naïve patients with pituitary disease were included. Patients with a known history of depression or psychiatric disorder were excluded. PHQ-9 standardized interpretation criteria were utilized to classify depression severity. For BIS-11, threshold was established based on previous studies. Statistical analysis was with SPSS version 25. Results: Seventy-six DA-treated and 27 naïve patients were included...Continue Reading

References

Sep 15, 2001·Journal of General Internal Medicine·K KroenkeJ B Williams
Dec 14, 2002·Health Services Research·Michael SchoenbaumKenneth B Wells
Dec 9, 2003·The Journal of Clinical Investigation·Shlomo Melmed
Jul 13, 2006·Archives of Neurology·Daniel WeintraubMatthew B Stern
May 20, 2009·Movement Disorders : Official Journal of the Movement Disorder Society·Daniel WeintraubValerie Voon
Apr 2, 2010·The New England Journal of Medicine·Anne Klibanski
Feb 8, 2011·The Journal of Clinical Endocrinology and Metabolism·Shlomo MelmedUNKNOWN Endocrine Society
Jul 9, 2011·Clinical Neuropharmacology·Jana MartinkovaPeter Valkovic
Oct 23, 2013·Journal of Neuro-oncology·Mark E Molitch
Jul 18, 2014·International Journal of High Risk Behaviors & Addiction·Nour-Mohammad Bakhshani
Sep 1, 2012·Journal of Behavioral Addictions·Rory C ReidTimothy Fong
Jan 15, 2016·Psychiatric Services : a Journal of the American Psychiatric Association·Samantha A LouzonIra R Katz
Sep 2, 2017·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Marie Grall-BronnecGaëlle Challet-Bouju
Nov 8, 2018·European Journal of Endocrinology·Adriana G IoachimescuLaurence Katznelson
Feb 2, 2019·The Psychiatric Clinics of North America·Anja Hilbert
Feb 12, 2019·Frontiers in Endocrinology·Xiaoshuang LiuChiyuan Ma
Mar 9, 2019·The Journal of Clinical Endocrinology and Metabolism·Sema Ciftci DogansenSema Yarman
May 18, 2019·Drugs·José Miguel Hinojosa-AmayaMaria Fleseriu
Oct 4, 2019·The Journal of Clinical Endocrinology and Metabolism·Sunita M C De SousaDavid J Torpy
Mar 5, 2020·The New England Journal of Medicine·Shlomo Melmed

❮ Previous
Next ❯

Related Concepts

Related Feeds

Addiction

This feed focuses mechanisms underlying addiction and addictive behaviour including heroin and opium dependence, alcohol intoxication, gambling, and tobacco addiction.

Related Papers

Revista brasileira de psiquiatria : orgão oficial da Associação Brasileira de Psiquiatria, Asociación Psiquiátrica de la América Latina
Leandro F Malloy-DinizPaulo Mattos
© 2021 Meta ULC. All rights reserved